Fig. 4. Pulmonary syndecan-1 inversely correlates with systemic shed syndecan-1 in plasma. (A) Comparison of intact pulmonary (measured in fluorescent intensity, left Y-axis) and shed plasma syndecan-1 (measured in fold change, right Y-axis) after a 10% TBSA and a 25% TBSA burn injury over time. Immunostaining of intact syndecan-1 inversely correlated with systemically shed syndecan-1 detected in plasma beginning at hour 4 in the 10% TBSA injury and (B) at all time points in the 25% TBSA injury.
